The NY State Menopause Leave Bill Has Four Problems. None of Them Are Related to Menopause.
A bill moving through the New York State Legislature is designed to help women. But, before New York State Legislators build menopause leave into law, four structural problems raised by A10296, A10270, and the companion Senate bills need to be named and addressed.
Naming the problems is not an argument against the bill. It is an argument for building it strategically, with consideration of certain facts.
Structural Problem One — The premium arrives before the assistance does.
The moment menopause is classified as a compensable condition under workers’ compensation law, some employers with New York operations pay higher premiums. Not when a claim is filed. Before.
Actuarial repricing is triggered by the classification itself. The employer absorbs the cost before a single employee takes a single day of leave. That is not a design feature; it is a design flaw.
To properly understand the cost to employers, keep in mind that the New York State Workers’ Compensation Board assessment rate is 7% of standard premium. Nearly 60,000 employers insure more than 820,000 employees through NYSIF Disability and Paid Leave Benefits alone. The moment menopause is added as a compensable condition under that system, every one of those employers is affected before a single claim is filed.
A bill designed to help women would land the hardest on small businesses which make up 97% of those 58,000 employers before a single woman takes a single day of leave.
Structural Problem Two — The women who need it most will not use it.
Here is the pathway the bill requires for utilization: a woman must name her condition, file a request, generate documentation, and move through an approval process.
For a senior executive in a market-moving environment, being seen as someone whose capacity is in question is a dealbreaker. The data confirms this is not a fringe concern; stigma is real. In a global survey of more than 8,000 women, only 27% had spoken with senior leadership about their situation. In a parallel survey of 898 working women, 97% concealed or downplayed their condition at work.
The women the bills are designed to help are the women least likely to engage the infrastructure they create.
Structural Problem Three — The measurement is broken before it begins.
The bill directs the Commissioner of Labor to develop workplace guidance on menopause based on the data the program generates. That data will count utilization. It will count filed claims and approved requests.
It will not count the women who assessed the personal cost of filing and decided against it.
The guidance will be calibrated strictly to the disclosed population. The undisclosed population will remain invisible. Policy will conclude the problem is smaller than it is, and the next round of legislation will hit the exact same ceiling.
Structural Problem Four — The bill does not say which menopause counts.
The statutory text of NY Assembly Bill A10270 defines menopause through a generic list of physical symptoms, but it completely omits surgical menopause, premature menopause, medically induced menopause, chemotherapy-induced menopause, or menopause caused by ovarian removal.
That omission matters because a woman can be 23 years old and be in menopause due to fibroids, cancer treatment, major surgery, or an unexpected medical event.
Because the law does not explicitly map these clinical paths, the actual execution of the protection is left entirely to the subjective recognition of employers, corporate insurers, physicians, and claims administrators. The women most likely to be aggressively questioned, or denied, are the younger workers whose profiles do not fit the demographics of the claims department. That is not a minor drafting issue; it is an operational blind spot that invites discriminatory scrutiny.
What New York’s Menopause Leave Bills Need
These bills do not need to be repealed; they need to be redesigned. This can be achieved by separating the leave entitlement from the workers’ compensation classification and removing the disclosure requirement from the measurement architecture.
We must start by building the guidance framework around what the data cannot see, not just what it can. The women these bills were written to help deserve infrastructure that is designed to reach them.
The awareness lobby is right that menopause belongs in workplace policy. The data is real, and the need is well documented. But as written, the bills will raise employer costs, produce incomplete data, and systematically exclude the women they want to help.
Commission a Strategic Briefing
Menopause-at-work legislation is creating a new workforce-risk record for employers. Lozen Advisory advises senior executives, CFOs, General Counsel, and corporate boards on accommodation exposure, disclosure-dependent measurement gaps, retention risk, and the organizational consequences of policies that activate only after an employee is willing to become visible.
